Abstract:The beta-catenin pathway plays a critical role in the pathogenesis of certain types of cancers. To gain insight into mechanisms by which altered receptor tyrosine kinases regulate cytoplasmic beta-catenin accumulation, the effect of an oncogenic receptor originated from Nantes (RON) variant on beta-catenin accumulation and the role of beta-catenin in RON-mediated tumorigenic activities were studied. In NIH3T3 cells harboring oncogenic variant RON Delta 160, increased beta-catenin accumulation with tyrosine phosphorylation and nuclear translocation was observed. Overexpression of RON Delta 160 also resulted in increased expression of beta-catenin target genes c-myc and cyclin D1. By analyzing cellular proteins that regulate beta-catenin stabilities, it was found that RON Delta 160 activates the protein disheveled (DVL) and inactivates glycogen synthase kinase-3 beta by Ser-9 residue phosphorylation. These effects were channeled by RON Delta 160-activated PI 3-kinase-AKT pathways that are sensitive to specific inhibitors, such as wortmannin, but not to other chemical inhibitors. Silencing RON Delta 160 expression by specific small interfering RNA blocked not only beta-catenin expression but also c-myc and cyclin D1 expression, suggesting that RON expression is required for the activation of the beta-catenin signaling pathway. Moreover, it was found that knockdown of the beta-catenin gene expression by small interfering RNA techniques reduces significantly the RON Delta 160-mediated NIH3T3 cell proliferation, focus-forming activities and anchorage-independent growth. Thus, the oncogenic RON variant regulates beta-catenin stabilities through activation of DVL and inactivation of glycogen synthase kinase-3 beta. The activated beta-catenin cascade is one of the pathways involved in tumorigenic activities mediated by the oncogenic RON variant.

Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6

Inhibition Of Gsk3 Phosphorylation Of Beta-Catenin Via Phosphorylated Pppspxs Motifs Of Wnt Coreceptor Lrp6

A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Β-Trcp Couples Β-Catenin Phosphorylation-Degradation and Regulates Xenopus Axis Formation

Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling

GSK3 Inhibits Macropinocytosis and Lysosomal Activity through the Wnt Destruction Complex Machinery

Phase Separation of Axin Organizes the Β-Catenin Destruction Complex.

Analysis of tumor-associated AXIN1 missense mutations identifies variants that activate β-catenin signaling

GSK3beta is Involved in JNK2-mediated Beta-Catenin Inhibition.

β-catenin stimulates Tcf7l1 degradation through recruitment of casein kinase 2 in mouse embryonic stem cells.

Liquid–liquid Phase Separation Drives the Β‐catenin Destruction Complex Formation

Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction

Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3β

Protein-tyrosine Phosphatase PCP-2 Inhibits Β-Catenin Signaling and Increases E-cadherin-dependent Cell Adhesion*

Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Differential Molecular Assemblies Underlie the Dual Function of Axin in Modulating the Wnt and JNK Pathways

A Mechanism for Wnt Coreceptor Activation.

Wnt11/Beta-Catenin Signaling In Both Oocytes And Early Embryos Acts Through Lrp6-Mediated Regulation Of Axin

Wnt-independent Beta-Catenin Transactivation in Tumor Development.